CCL Featured Stories, Homepage Featured Stories, Resources, Special Communication
May 2019: Changes to Reference Ranges & Test Builds
Special Communication
Reference Range Changes
Cysticercus IgG Ab, Serum (CYSGBL)
Reference Range
< or = 0.8 IV: Negative
No significant level of cysticercosis IgG antibody detected
0.9 – 1.1 IV: Equivocal
Questionable presence of cysticercosis IgG antibody detected; repeat testing in 10-14 days may be helpful
> or = 1.2 IV: Positive
IgG antibodies to cysticercosis detected, which may suggest current or past infection
Liver Fibrosis, FibroTest-ActiTest (LIVFIB)
Reference Range
Apolipoprotein A1
– Male: > or = 115 mg/dL
– Female: > or = 125 mg/dL
Note: There will be no other range changes
Galactose Quant, Plasma (GALAC)
Reference Range
< or = 7 days: < 5.4 mg/dL
8 – 14 days: < 3.6 mg/dL
> or = 15 days: < 2.0 mg/dL
Hemoglobin A2 (HBA2)
Reference Range
2.0 – 3.1%
Hemoglobin A2 and F (A2F)
Reference Range
Hemoglobin Fetal: 0.0 – 0.9%
Hemoglobin A2 Percent: 2.0 – 3.1%
Hemoglobin Fetal (HBF)
Reference Range
0.0 – 0.9%
Vancomycin (VANCRA)
Reference Range
0 – 99 Years: 10.0 – 20.0 µg/mL
Discontinued Tests
Degradation Products (FDP)
Due to the lack of availability of the appropriate tubes, this test has been discontinued.
We suggest ordering D-Dimer (DDMER).
Any additional information regarding these changes will be included in a future Technical Update.
If you have any questions about this change, please contact Client Services for assistance.
Comments are closed